Published in Cell Immunol on February 01, 1990
Thymus-marrow cell combinations. Synergism in antibody production. Proc Soc Exp Biol Med (1966) 10.03
Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence. Transplant Rev (1969) 6.39
Corticosteroids and lymphoid cells. N Engl J Med (1972) 5.69
Immunocompetence of transferred thymus-marrow cell combinations. J Immunol (1966) 4.52
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol (2008) 4.18
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol (2009) 3.45
Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35
Hydrocortisne resistance of graft vs host activity in mouse thymus, spleen and bone marrow. J Immunol (1970) 2.83
Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy. Br J Dermatol (2012) 2.67
Thymus-marrow immunocompetence. V. Hydrocortisone-resistant cells and processes in the hemolytic antibody response of mice. J Exp Med (1971) 2.46
Electroimmunodiffusion (EID): a simple, rapid method for quantitation of immunoglobulins in dilute biological fluids. J Lab Clin Med (1967) 2.37
Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells". J Immunol (1974) 2.25
Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation. J Immunol (1974) 2.18
High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol (2009) 2.13
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J Exp Med (1979) 2.09
Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2009) 2.04
Bone marrow and spleen: dissociation of immunologic properties by cortisone. Science (1970) 2.02
Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes (2001) 1.93
Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. J Immunol (1977) 1.87
A splenic requirement for the generation of suppressor T cells. J Immunol (1977) 1.86
MR imaging and spectroscopy using hyperpolarized 129Xe gas: preliminary human results. Magn Reson Med (1997) 1.80
Role of the macrophage in natural resistance to salmonellosis in mice. Infect Immun (1972) 1.73
Suppressive mechanisms involving sensitization and tolerance in contact allergy. Immunol Rev (1980) 1.72
How corticosteroids work. J Allergy Clin Immunol (1975) 1.70
The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction. J Immunol (1976) 1.68
Corticosteroids and lymphoid cells in vitro. I. Hydrocortisone lysis of human, guinea pig, and mouse thymus cells. J Lab Clin Med (1971) 1.66
The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. Eur J Immunol (1977) 1.66
Tetrahydrobiopterin deficiency in human rabies. J Inherit Metab Dis (2008) 1.56
Control of experimental contact sensitivity. Adv Immunol (1980) 1.54
Identification of Francisella tularensis by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry: fast, reliable, robust, and cost-effective differentiation on species and subspecies levels. J Clin Microbiol (2010) 1.51
Site of action of cortisol in cellular immunity. J Immunol (1973) 1.46
Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow. Cell Immunol (1972) 1.43
Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa. J Rheumatol (1981) 1.42
Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response. J Immunol (1976) 1.39
Fusion of computed tomography data and optical 3D images of the dentition for streak artefact correction in the simulation of orthognathic surgery. Dentomaxillofac Radiol (2004) 1.38
Human thymus cell cultures-evidence for two functional populations. Proc Soc Exp Biol Med (1966) 1.36
Immunologic reactions to haptens on autologous carriers. I. Participation of both thymus-derived and bone marrow-derived cells in the secondary in vitro response. J Exp Med (1973) 1.36
Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med (1985) 1.34
Identification of a major facilitator protein from Escherichia coli involved in efflux of metabolites of the cysteine pathway. Mol Microbiol (2000) 1.34
Suppressor T cell mechanisms in contact sensitivity. I. Efferent blockade by syninduced suppressor T cells. J Immunol (1978) 1.31
Aeromonas aquariorum sp. nov., isolated from aquaria of ornamental fish. Int J Syst Evol Microbiol (2008) 1.29
Characterisation of a protease from Escherichia coli involved in hydrogenase maturation. Eur J Biochem (1995) 1.28
Migration of antibody-forming cells and antigen-sensitive precursors between spleen, thymus and bone marrow. Immunology (1968) 1.27
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol (1994) 1.26
Serum immunoglobulins in rheumatoid arthritis. J Lab Clin Med (1966) 1.25
Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA. J Immunol (1985) 1.24
Tolerance and contact sensitivity to DNFB in mice. V. Induction of tolerance with DNP compounds and with free and membrane-associated DNFB. J Immunol (1976) 1.22
H-2 restriction of suppressor T-cell induction by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitization. J Exp Med (1977) 1.20
Subpopulations of mouse T lymphocytes. I. "Thymidine suicide" of a major proliferating, PHA-responsive cell population present in spleen but not in lymph node. J Immunol (1974) 1.19
Tolerance: two pathways of negative immunoregulation in contact sensitivity to DNFB. Cold Spring Harb Symp Quant Biol (1977) 1.19
Regulation of cell mediated immunity by antibodies: possible role of anti-receptor antibodies in the regulation of contact sensitivity to DNFB in mice. J Immunol (1979) 1.19
Serum immunoglobulin measurement during the first year of life and in immunoglobulin-deficiency states. J Pediatr (1966) 1.18
Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin). J Exp Med (1972) 1.18
Signal peptide-selection of cDNA cloned directly from the esophageal gland cells of the soybean cyst nematode Heterodera glycines. Mol Plant Microbe Interact (2001) 1.17
Requirements for induction of T cell tolerance to DNFB: efficiency of membrane-associated DNFB. J Immunol (1976) 1.16
Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol (1983) 1.15
Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn Reson Med (2001) 1.13
Inhibition of antibody production and acquired immunologic tolerance by actinomycin. J Immunol (1965) 1.12
Identification of putative parasitism genes expressed in the esophageal gland cells of the soybean cyst nematode Heterodera glycines. Mol Plant Microbe Interact (2001) 1.08
Tolerance and contact sensitivity to DNFB in mice. II. Specific in vitro stimulation with a hapten, 2,4-dinitrobenzene sulfonic acid (DNB-SO3Na). J Immunol (1974) 1.04
Thymus-marrow immunocompetence. IV. The growth and immunocompetence of transferred marrow, thymus, and spleen cells in parent and F1 hybrid mice. Transplantation (1969) 1.04
Age-related changes in cell-mediated immunity in BALB/C mice. J Immunol (1975) 1.03
Human necrotizing vasculitis: immunoglobulins and complement in vessel walls of cutaneous lesions and normal skin. J Invest Dermatol (1975) 1.02
Changes in serum immunoglobulin and complement levels following renal homotransplantation. Transplantation (1970) 1.02
Suppressor T cell circuits in contact sensitivity. I. Two mechanistically distinct waves of suppressor T cells occur in mice tolerized with syngeneic DNP-modified lymphoid cells. J Immunol (1982) 1.01
Quantitation of immunoglobulins in cerebrospinal fluid. Arch Neurol (1966) 1.01
Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells". J Immunol (1986) 1.01
Isolated severe gamma A deficiency: immunoglobulin levels, clinical disorders, and chromosome studies. J Lab Clin Med (1970) 1.00
The response of cultured human thymus cells to phytohemagglutinin. J Immunol (1968) 0.99
Efficient induction of immediate tolerance to contact sensitivity by hapten-modified spleen cells requires Ia+ cells compatible with recipient. Nature (1979) 0.99
Perfusion imaging of the human lung using flow-sensitive alternating inversion recovery with an extra radiofrequency pulse (FAIRER). Magn Reson Imaging (1999) 0.99
Histiocytic reaction in dysgammaglobulinemia and congenital rubella. Pediatrics (1970) 0.97
Amyloid-associated muscle pseudohypertrophy. Arch Neurol (1982) 0.97
Bone marrow T cells. II. Thymic dependency. Cell Immunol (1974) 0.97
Suppressor T cell mechanisms in contact sensitivity. II. Afferent blockade by alloinduced suppressor T cells. J Immunol (1978) 0.96
Cortisol inhibition of immunologic activity in guinea pig alveolar cells. Int Arch Allergy Appl Immunol (1974) 0.96
Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie (2004) 0.96
Molecular characterisation and expression of two venom allergen-like protein genes in Heterodera glycines. Int J Parasitol (2001) 0.95
Cell-cell interactions in antibody production. Prog Allergy (1972) 0.95
Postburn immunosuppression in an animal model. II. Restoration of cell-mediated immunity by immunomodulating drugs. Surgery (1984) 0.95
Vasculitis in chronic urticaria. J Allergy Clin Immunol (1980) 0.95
Hypogammaglobulinemia, primary and secondary: immunoglobulin levels (gamma-G, gamma-A, gamma-M) in one hundred and twenty-five patients. J Allergy (1966) 0.95
Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol (1985) 0.95
Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance. Gynecol Oncol (1990) 0.95
Salivary immunoglobulin and albumin: development during the newborn period. J Pediatr (1968) 0.94
Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol (1977) 0.93
Hypothesis. T-cell tolerance--one signal? Cell Immunol (1979) 0.92
Murine graft-versus-host disease across minor barriers: immunosuppressive aspects of natural suppressor cells. Immunol Rev (1985) 0.92
Hertel exophthalmometry versus computed tomography and optical 3D imaging for the determination of the globe position in zygomatic fractures. Int J Oral Maxillofac Surg (2004) 0.91
Thymus-marrow immunocompetence. 3. The requirement for living thymus cells. Proc Soc Exp Biol Med (1968) 0.91
Tolerance to contact hypersensitivity. Contemp Top Immunobiol (1976) 0.91
Salivary immunoglobulins: normal adult values and dissociation between serum and salivary levels. J Allergy (1967) 0.90
Evidence that IFN-gamma is responsible for natural suppressor activity in GVHD spleen and normal bone marrow. Transplantation (1988) 0.89
Natural suppressor activity in graft-vs-host spleen and normal bone marrow is augmented by IL 2 and interferon-gamma. J Immunol (1986) 0.89
Differential suppressive effect of hydrocortisone on lymphocytes and mononuclear macrophages in delayed hypersensitivity of guinea pigs. J Invest Dermatol (1972) 0.89